• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于药代动力学和药效学数据拟合与模拟的算法及R程序

An Algorithm and R Program for Fitting and Simulation of Pharmacokinetic and Pharmacodynamic Data.

作者信息

Li Jijie, Yan Kewei, Hou Lisha, Du Xudong, Zhu Ping, Zheng Li, Zhu Cairong

机构信息

Department of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, China, No. 17 Section 3, Renmin South Road, Chengdu, 610041, Sichuan, China.

College of Mathematics, Sichuan University, China, No. 24 South Section 1, Yihuan Road, Chengdu, 610065, Sichuan, China.

出版信息

Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):499-518. doi: 10.1007/s13318-016-0358-x.

DOI:10.1007/s13318-016-0358-x
PMID:27488206
Abstract

BACKGROUND AND OBJECTIVES

Pharmacokinetic/pharmacodynamic link models are widely used in dose-finding studies. By applying such models, the results of initial pharmacokinetic/pharmacodynamic studies can be used to predict the potential therapeutic dose range. This knowledge can improve the design of later comparative large-scale clinical trials by reducing the number of participants and saving time and resources. However, the modeling process can be challenging, time consuming, and costly, even when using cutting-edge, powerful pharmacological software. Here, we provide a freely available R program for expediently analyzing pharmacokinetic/pharmacodynamic data, including data importation, parameter estimation, simulation, and model diagnostics.

METHODS

First, we explain the theory related to the establishment of the pharmacokinetic/pharmacodynamic link model. Subsequently, we present the algorithms used for parameter estimation and potential therapeutic dose computation. The implementation of the R program is illustrated by a clinical example. The software package is then validated by comparing the model parameters and the goodness-of-fit statistics generated by our R package with those generated by the widely used pharmacological software WinNonlin.

RESULTS

The pharmacokinetic and pharmacodynamic parameters as well as the potential recommended therapeutic dose can be acquired with the R package. The validation process shows that the parameters estimated using our package are satisfactory.

CONCLUSIONS

The R program developed and presented here provides pharmacokinetic researchers with a simple and easy-to-access tool for pharmacokinetic/pharmacodynamic analysis on personal computers.

摘要

背景与目的

药代动力学/药效学连接模型在剂量探索研究中广泛应用。通过应用此类模型,初始药代动力学/药效学研究结果可用于预测潜在治疗剂量范围。这一知识可通过减少参与者数量、节省时间和资源来改进后续比较大规模临床试验的设计。然而,建模过程可能具有挑战性、耗时且成本高昂,即便使用前沿、强大的药理学软件亦是如此。在此,我们提供一个免费的R程序,用于便捷地分析药代动力学/药效学数据,包括数据导入、参数估计、模拟和模型诊断。

方法

首先,我们解释与药代动力学/药效学连接模型建立相关的理论。随后,我们介绍用于参数估计和潜在治疗剂量计算的算法。通过一个临床实例说明R程序的实现。然后通过将我们的R软件包生成的模型参数和拟合优度统计量与广泛使用的药理学软件WinNonlin生成的进行比较,对该软件包进行验证。

结果

使用该R软件包可获取药代动力学和药效学参数以及潜在推荐治疗剂量。验证过程表明,使用我们的软件包估计的参数令人满意。

结论

此处开发并展示的R程序为药代动力学研究人员提供了一个简单且易于在个人计算机上进行药代动力学/药效学分析的工具。

相似文献

1
An Algorithm and R Program for Fitting and Simulation of Pharmacokinetic and Pharmacodynamic Data.一种用于药代动力学和药效学数据拟合与模拟的算法及R程序
Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):499-518. doi: 10.1007/s13318-016-0358-x.
2
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.PKSolver:一个在 Microsoft Excel 中进行药代动力学和药效动力学数据分析的插件程序。
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14. doi: 10.1016/j.cmpb.2010.01.007. Epub 2010 Feb 21.
3
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.PFIM 4.0,一个用于非线性混合效应模型设计评估和优化的扩展 R 程序。
Comput Methods Programs Biomed. 2018 Mar;156:217-229. doi: 10.1016/j.cmpb.2018.01.008. Epub 2018 Jan 11.
4
A calculator package for pharmacokinetic application.
Comput Programs Biomed. 1983 Dec;17(3):277-82. doi: 10.1016/0010-468x(83)90049-1.
5
CPhaMAS: An online platform for pharmacokinetic data analysis based on optimized parameter fitting algorithm.CPhaMAS:一个基于优化参数拟合算法的在线药代动力学数据分析平台。
Comput Methods Programs Biomed. 2024 May;248:108137. doi: 10.1016/j.cmpb.2024.108137. Epub 2024 Mar 19.
6
Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.比较FOCE与不同期望最大化方法在处理复杂群体生理药代动力学模型方面的性能。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):359-70. doi: 10.1007/s10928-016-9476-y. Epub 2016 May 23.
7
Design and pharmacokinetic application of an analog computer program (MULS) for multiple dose simulation.用于多剂量模拟的模拟计算机程序(MULS)的设计与药代动力学应用。
Comput Biomed Res. 1983 Oct;16(5):469-82. doi: 10.1016/0010-4809(83)90035-6.
8
gPKPDSim: a SimBiology-based GUI application for PKPD modeling in drug development.gPKPDSim:一个基于 SimBiology 的 GUI 应用程序,用于药物开发中的 PKPD 建模。
J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):259-275. doi: 10.1007/s10928-017-9562-9. Epub 2018 Jan 4.
9
Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.在非线性混合效应(NLME)中使用微分方程进行药代动力学/药效学建模。
Comput Methods Programs Biomed. 2004 Oct;76(1):31-40. doi: 10.1016/j.cmpb.2004.01.001.
10
MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes.MicroPharm-K,一个用于药代动力学过程分析与模拟的微型计算机交互式程序。
Pharm Res. 1995 Aug;12(8):1225-30. doi: 10.1023/a:1016280430580.

引用本文的文献

1
Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy based on the age.基于年龄的个性化治疗,使用基于物理的模拟预测经皮芬太尼传递。
Drug Deliv. 2022 Dec;29(1):950-969. doi: 10.1080/10717544.2022.2050846.
2
A Use of Tritium-Labeled Peat Fulvic Acids and Polyphenolic Derivatives for Designing Pharmacokinetic Experiments on Mice.氚标记的泥炭黄腐酸和多酚衍生物在小鼠药代动力学实验设计中的应用。
Biomedicines. 2021 Nov 29;9(12):1787. doi: 10.3390/biomedicines9121787.
3
Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study.

本文引用的文献

1
[Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model].[基于非线性混合效应模型的华法林群体药代动力学/药效学建模]
Yao Xue Xue Bao. 2015 Oct;50(10):1280-4.
2
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.儿科传染病与免疫学中的药代动力学/药效学建模方法
Adv Drug Deliv Rev. 2014 Jun;73(100):127-39. doi: 10.1016/j.addr.2014.01.002. Epub 2014 Jan 17.
3
Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs.抗菌药物的药代动力学-药效学建模。
用于预测肾病综合征患儿麦考酚酸 AUC 的有限采样策略:一项回顾性队列研究。
Eur J Clin Pharmacol. 2019 Sep;75(9):1249-1259. doi: 10.1007/s00228-019-02701-5. Epub 2019 Jun 6.
Pharmacol Rev. 2013 Jun 26;65(3):1053-90. doi: 10.1124/pr.111.005769. Print 2013 Jul.
4
Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.生理基于药代动力学组织隔室模型在药物研发和风险评估中的选择。
J Pharm Sci. 2012 Jan;101(1):424-35. doi: 10.1002/jps.22768. Epub 2011 Oct 3.
5
Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: compartmental analysis and PK-PD evaluation.新型四氢喹啉类似物在兔眼中的药代动力学:房室分析和 PK-PD 评价。
J Pharm Sci. 2012 Jan;101(1):414-23. doi: 10.1002/jps.22764. Epub 2011 Sep 20.
6
Heteroscedastic nonlinear regression models based on scale mixtures of skew-normal distributions.基于偏态正态分布尺度混合的异方差非线性回归模型。
Stat Probab Lett. 2011 Aug 1;81(8):1208-1217. doi: 10.1016/j.spl.2011.03.019.
7
Understanding the time course of pharmacological effect: a PKPD approach.理解药效的时间过程:一种 PKPD 方法。
Br J Clin Pharmacol. 2011 Jun;71(6):815-23. doi: 10.1111/j.1365-2125.2011.03925.x.
8
Non-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed model.非房室模型到房室模型的药代动力学转换的Meta分析——一种多元非线性混合模型
BMC Syst Biol. 2010 May 28;4 Suppl 1(Suppl 1):S8. doi: 10.1186/1752-0509-4-S1-S8.
9
Practical considerations for optimal designs in clinical dose finding studies.临床剂量探索研究中最优设计的实际考虑。
Stat Med. 2010 Mar 30;29(7-8):731-42. doi: 10.1002/sim.3802.
10
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.PKSolver:一个在 Microsoft Excel 中进行药代动力学和药效动力学数据分析的插件程序。
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14. doi: 10.1016/j.cmpb.2010.01.007. Epub 2010 Feb 21.